Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene

Genes and Immunity

Volumn 3, Issue 1, 2002, Pages 14-19

  Szalai, Alex J ^a   McCrory, M A ^a   Cooper, G S ^b   Wu, J ^a   Kimberly, R P ^a  

^a University of Alabama at Birmingham   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acute phase proteins; Inflammation; Risk factors

Indexed keywords

C REACTIVE PROTEIN; GUANINE; THYMINE; MICROSATELLITE DNA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INFLAMMATORY DISEASE; INTRON; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STRATIFICATION; SYSTEMIC LUPUS ERYTHEMATOSUS; AGE; ALLELE; AMERICAN INDIAN; ASIAN AMERICAN; BLOOD; CAUCASIAN; COMPARATIVE STUDY; GENE DOSAGE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; NEGRO; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PHENOTYPE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ALLELES; ASIAN AMERICANS; BASE SEQUENCE; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; INDIANS, NORTH AMERICAN; INTRONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0036482654     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363820     Document Type: Article

References (43)

1. Shrive AK, Cheetham GMT, Holden D et al. Three dimensional structure of human C-reactive protein. Nat Struct Biol 1996; 3: 346-354.
2. Volanakis JE, Kaplan MH. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 1971; 136: 612-614.
3. Agrawal A, Kilpatrick JM, Volanakis JE. Structure and function of human C-reactive protein. In: Mackiewicz A, Kushner I, Baumann H (eds). Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. CRC Press: Ann Arbor MI, 1993, pp 79-92.
4. Volanakis JE, Xu Y, Macon KJ. Human C-reactive protein and host defense. In: Marchalonis JJ, Reinisch CL (eds). Defense Molecules. Alan R Liss: New York, 1990, pp 161-175.
5. Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphinogomyelin. J Immunol 1974; 112: 2135-2147.
6. Marnell LL, Mold C, Volzer MA, Burlingame RW, DuClos TW. C-reactive protein binds to FcγRI in transfected COS cells. J Immunol 1995; 155: 2185-2193.
7. Stein M-P, Mold C, DuClos TW. C-reactive protein binding to murine leukocytes requires Fcγ receptors. J Immunol 2000; 164: 1514-1520.
8. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995; 155: 2557-2563.
9. Szalai AJ, VanCott JL, McGhee JR, Volanakis JE, Benjamin WH Jr. Human C-reactive protein is protective against fatal Salmonella enterica Serovar Typhimurium infection in transgenic mice. Infect Immun 2000; 68: 5652-5656.
10. Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000; 192: 1353-1363.
11. Rosen A, Casciola-Rosen L. Clearing the way to mechanisms of autoimmunity. Nat Med 2001; 7: 664-665.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
13. Westhuyzen J, Healy H. Review: biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 2000; 30: 133-143.
14. Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992; 37: 313-336.
15. Gabay C, Roux-Lombard P, de Moerloose P, Dayer J-M, Vischer T, Guerne P-A. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993; 20: 815-821.
16. Pepys MB, Lanham JG, DeBeer FC. C-reactive protein in SLE. Clin Rheum Dis 1982; 8: 91-103.
17. DuClos TW, Zlock LT, Rubin RL. Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol 1988; 141: 4266-4270.
18. Minota S, Morino N, Sakurai H, Yamada A, Yazaki Y. Interrelationship between autoepitope, DNA-binding domain, and CRP-binding domain on a histone H1 molecule. Clin Immunol Immunopathol 1993; 66: 269-271.
19. DuClos TW. C-reactive protein reacts with U1 small nuclear ribonucleoproteins. J Immunol 1989; 143: 2553-2559.
20. Robey FA, Jones KD, Steinberg AD. C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. J Exp Med 1985; 161: 1344-1356.
21. 1 mice treated with C-reactive protein. Clin Immunol Immunopathol 1994; 70: 22-27.
22. Burlingame RW, Volzer MA, Harris J, DuClos TW. The effects of acute phase proteins on clearance of chromatin from the circulation of normal mice. J Immunol 1996; 156: 4783-4788.
23. Szalai AJ, Marion TN, Weaver CT, Volanakis JE. Human C-reactive protein (CRP) is protective against murine SLE in NZB/W F1 mice. Clin Exp Rheumatol 1998; 16: 201 (Abstr. 24).
24. Szalai AJ, van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, Volanakis JE. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 1998; 160: 5294-5299.
25. Maire MA, Barnet B, Carpenter N, Miescher PA, Lambert P-H. Identification of components of IC purified from human sera. I. Immune complexes purified from sera of patients with SLE. Clin Exp Immunol 1983; 51: 215-224.
26. Shai R, Quismorio FP, Li L et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999; 8: 639-644.
27. Moser KL, Gray-McGuire C, Kelly J et al. Genetic linkages to human systemic lupus erythematosus. FASEB J 2000; 14: A1210 (Abstr. 186.30).
28. Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869-14874.
29. Walsh MT, Divane A, Whitehead AS. Fine mapping of the human pentraxin gene region on chromosome 1q23. Immunogenetics 1996; 44: 62-69.
30. Lei K-J, Liu T, Zon G, Soravia E, Liu T-Y, Goldman ND. Genomic DNA sequence for human C-reactive protein. J Biol Chem 1985; 260: 13377-13383.
31. Woo P, Korenberg JR, Whitehead AS. Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary sequence of serum amyloid P component. J Biol Chem 1985; 260: 13384-13388.
32. Weber JL, Kwitek AE, May PE. Dinucleotide repeat polymorphism at the CRP locus. Nucl Acid Res 1990; 18: 4635.
33. Pankow JS, Folsom AR, Cushman M et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atheriosclerosis 2001; 154: 681-689.
34. Margaglione M, Cappucci G, Colaizzo D, Vecchione G, Grandone E, Di Minno G. C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives. Arterioscler Thromb Vasc Biol 2000; 20: 198-203.
35. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taq1 polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
36. Pandey JP, Takeuchi F. TNF-α and TNF-β gene polymorphism in systemic sclerosis. Human Immunol 1999; 60: 1128-1130.
37. Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV. A single nucleotide polymorphism in the first intron of the IFN-γ gene: Absolute correlation with a polymorphic CA microsatellite marker of high INF-γ production. Human Immunol 2000; 61: 863-866.
38. Watson JD, Crick FHC. A structure for deoxyribose nucleic acid. Nature 1953; 171: 737-738.
39. Adler AJ, Scheller A, Robins DM. The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences. Mol Cell Biol 1993; 13: 6326-6335.
40. Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biological aging. Cleve Clin J Med 2001; 68: 535-537.
41. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995; 38: 1260-1270.
42. Stein MP, Edberg JC, Kimberly RP et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 2000; 105: 369-376.
43. Salmon JE, Millard S, Schachter LA et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348-1354.